• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    3/8/24 1:47:01 PM ET
    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $ADAP alert in real time by email

    Shares of Marvell Technology, Inc. (NASDAQ:MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

    Marvell said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarterly earnings of 46 cents per share, which was in line with analyst estimates.

    Marvell sees first-quarter revenue of $1.15 billion, plus or minus 5%, versus estimates of $1.371 billion. The company sees first-quarter adjusted earnings of 23 cents per share, plus or minus 5 cents per share, versus estimates of 40 cents per share. The company authorized a $3 billion buyback.

    Marvell Technology shares dipped 9.6% to $76.91 on Friday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    Ainos, Inc. (NASDAQ:AIMD) jumped 140% to $2.6899 after dipping 18% on Thursday.

    Psyence Biomedical Ltd. (NASDAQ:PBM) shares climbed 139% to $3.0350. Psyence Biomedical recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.

    Safe and Green Development Corporation (NASDAQ:SGD) shares jumped 138% to $1.57 after the company announced financing for the Norman Berry Expansion in Atlanta, Georgia.

    MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares climbed 48.5% to $1.36. MIRA Pharmaceuticals, last month, announced a research collaboration with Pharmaseed to research and evaluate Ketamir for patients with major depressive disorder and post-traumatic stress disorder.

    CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares climbed 35.4% to $4.17 after surging over 20% on Thursday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.

    Willdan Group, Inc. (NASDAQ:WLDN) gained 30.4% to $25.89 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years.

    The Joint Corp. (NASDAQ:JYNT) gained 29% to $11.80 following fourth-quarter results.

    Smith & Wesson Brands, Inc. (NASDAQ:SWBI) jumped 25.8% to $16.91 after the company reported better-than-expected third-quarter financial results.

    Research Frontiers Incorporated (NASDAQ:REFR) climbed 25.6% to $1.42 following fourth-quarter results.

    Gulf Island Fabrication, Inc. (NASDAQ:GIFI) shares gained 24.1% to $6.43 after the company reported a year-over-year increase in fourth-quarter revenue results.

    Grifols, S.A. (NASDAQ:GRFS) gained 22.7% to $6.89 after the company announced it published its consolidated annual accounts for 2023.

    DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) gained 21.6% to $14.25.

    Dogness (International) Corporation (NASDAQ:DOGZ) gained 18.6% to $7.98.

    Kidpik Corp. (NASDAQ:PIK) gained 18.3% to $3.0177.

    America's Car-Mart, Inc. (NASDAQ:CRMT) jumped 16.5% to $72.56 following third-quarter results.

    Porch Group, Inc. (NASDAQ:PRCH) rose 16.1% to $3.6099 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance.

    Samsara Inc. (NYSE:IOT) gained 14.3% to $39.28 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.

    Viracta Therapeutics, Inc. (NASDAQ:VIRX) shares gained 13.5% to $0.9200 following fourth-quarter results.

    Aeva Technologies, Inc. (NASDAQ:AEVA) rose 12.6% to $1.34.

    Adaptimmune Therapeutics plc (NASDAQ:ADAP) gained 12.1% to $1.95. Adaptimmune Therapeutics recently reported better-than-expected quarterly EPS results.

    HCI Group, Inc. (NYSE:HCI) gained 11.3% to $110.42 after the company reported better-than-expected fourth-quarter financial results.

    NuScale Power Corporation (NYSE:SMR) jumped 10.5% to $4.9289.

    Redfin Corporation (NASDAQ:RDFN) jumped 9.6% to $7.10.

    reAlpha Tech Corp. (NASDAQ:AIRE) rose 8.8% to $1.3599. reAlpha Tech, last month, appointed Michael Frenz as CFO and Mike Logozzo as President and COO.

    Carnival Corporation (NYSE:CCL) gained 5% to $16.44.

    Losers

    Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) shares fell 80.7% to $3.6596 after the company announced its PHOENIX phase 3 trial of AMX0035 for amyotrophic lateral sclerosis did not meet its primary endpoint and there was no statistical significance seen in secondary endpoints.

    BigBear.ai Holdings, Inc. (NYSE:BBAI) fell 30.8% to $2.6006 after the company reported worse-than-expected fourth-quarter financial results.

    Next.e.GO N.V. (NASDAQ:EGOX) tumbled 28.6% to $0.0819.

    Critical Metals Corp. (NASDAQ:CRML) fell 27.7% to $7.95.

    Swvl Holdings Corp. (NASDAQ:SWVL) fell 26.3% to $5.45.

    Immuron Limited (NASDAQ:IMRN) shares dipped 24.7% to $3.4250 after jumping 161% on Thursday.

    AerSale Corporation (NASDAQ:ASLE) fell 24.4% to $7.11 after the company reported worse-than-expected fourth-quarter financial results.

    CarParts.com, Inc. (NASDAQ:PRTS) fell 24.3% to $1.8999 following fourth-quarter results.

    Mobix Labs, Inc. (NASDAQ:MOBX) fell 20.1% to $1.39.

    Nxu, Inc. (NASDAQ:NXU) fell 19% to $0.8001 after surging 28% on Thursday. Nxu recently announced it successfully charged a Tesla Cybertruck.

    Brera Holdings PLC (NASDAQ:BREA) shares fell 16.9% to $1.62. Brera Holdings shares jumped 91% on Thursday after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company.

    Custom Truck One Source, Inc. (NYSE:CTOS) dipped 15.3% to $5.26 after the company reported mixed quarterly financial results.

    Nexalin Technology, Inc. (NASDAQ:NXL) fell 15.1% to $0.4627. Nexalin Technology recently announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.

    Runway Growth Finance Corp. (NASDAQ:RWAY) fell 13.5% to $11.68 following downbeat quarterly results.

    Domo, Inc. (NASDAQ:DOMO) fell 12.7% to $9.92 after the company issued soft first-quarter and FY25 guidance.

    MediaAlpha, Inc. (NYSE:MAX) declined 12.4% to $19.05 after the company announced a secondary offering of 3 million shares.

    Genesco Inc. (NYSE:GCO) fell 11.7% to $25.84 after the company's reported a fourth-quarter EPS miss and issued weak FY25 guidance.

    Delek Logistics Partners, LP (NYSE:DKL) fell 11.3% to $39.51 after the company priced a public offering of 3,116,884 common units at $38.50 per unit.

    Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 11% to $1.13 after jumping 65% on Thursday. The company announced that it entered into a non-binding letter of intent to acquire Arctic7.

    Traeger, Inc. (NYSE:COOK) fell 10.5% to $2.11 after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance below estimates.

    Aquestive Therapeutics, Inc. (NASDAQ:AQST) dipped 10% to $5.11 following fourth-quarter results.

    Petróleo Brasileiro S.A. - Petrobras (NYSE:PBR) shares fell 9.6% to $15.10 as the company reported a 6.3% year-over-year decline in its fourth-quarter net recurring profit.

    Costco Wholesale Corporation (NASDAQ:COST) fell 7.5% to $727.08 following mixed second-quarter results.

    MongoDB, Inc. (NASDAQ:MDB) declined 6.4% to $385.82 after the company issued weak FY25 guidance.

    Icahn Enterprises L.P. (NASDAQ:IEP) fell 4.7% to $17.85.

    RadNet, Inc. (NASDAQ:RDNT) dipped 4.1% to $46.54. RadNet priced its public offering of 4.55 million common stock at $44 per share.

    Now Read This: Cramer Says Sprout Social Is In A 'Hot Spot,' But This Energy Stock Is 'Too Down And Out'

    Get the next $ADAP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADAP
    $AEVA
    $AIMD
    $AIRE

    CompanyDatePrice TargetRatingAnalyst
    Costco Wholesale Corporation
    $COST
    2/27/2026$1185.00Buy
    BofA Securities
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    MongoDB Inc.
    $MDB
    2/26/2026$455.00 → $400.00Outperform
    BMO Capital Markets
    Samsara Inc.
    $IOT
    2/25/2026$50.00 → $40.00Outperform
    BMO Capital Markets
    Domo Inc.
    $DOMO
    2/13/2026$3.50Mkt Outperform → Mkt Underperform
    Citizens
    Samsara Inc.
    $IOT
    2/11/2026$36.00Buy
    Goldman
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    Porch Group Inc.
    $PRCH
    2/11/2026$10.50Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Jobson Charles E bought $130,874 worth of Common (15,397 units at $8.50), increasing direct ownership by 0.94% to 1,645,294 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    2/17/26 5:36:26 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Large owner Jobson Charles E bought $3,898 worth of Common (448 units at $8.70), increasing direct ownership by 0.03% to 1,639,597 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    2/13/26 5:16:01 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    Large owner Jobson Charles E bought $174,780 worth of Common (17,478 units at $10.00), increasing direct ownership by 1% to 1,639,149 units (SEC Form 4)

    4 - JOINT Corp (0001612630) (Issuer)

    1/27/26 8:45:38 PM ET
    $JYNT
    Multi-Sector Companies
    Miscellaneous

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    SEC Filings

    View All

    SEC Form 10-K filed by Delek Logistics Partners L.P.

    10-K - Delek Logistics Partners, LP (0001552797) (Filer)

    2/27/26 1:04:49 PM ET
    $DKL
    Natural Gas Distribution
    Energy

    reAlpha Tech Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - reAlpha Tech Corp. (0001859199) (Filer)

    2/27/26 8:51:25 AM ET
    $AIRE
    Real Estate
    Finance

    Delek Logistics Partners L.P. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Delek Logistics Partners, LP (0001552797) (Filer)

    2/27/26 6:32:10 AM ET
    $DKL
    Natural Gas Distribution
    Energy

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Costco with a new price target

    BofA Securities initiated coverage of Costco with a rating of Buy and set a new price target of $1,185.00

    2/27/26 8:31:30 AM ET
    $COST
    Department/Specialty Retail Stores
    Consumer Discretionary

    NuScale Power upgraded by Northland Capital with a new price target

    Northland Capital upgraded NuScale Power from Market Perform to Outperform and set a new price target of $21.00

    2/27/26 8:22:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    BMO Capital Markets reiterated coverage on MongoDB with a new price target

    BMO Capital Markets reiterated coverage of MongoDB with a rating of Outperform and set a new price target of $400.00 from $455.00 previously

    2/26/26 6:51:04 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Yi Steven sold $189,706 worth of shares (20,748 units at $9.14), decreasing direct ownership by 0.77% to 2,688,876 units (SEC Form 4)

    4 - MediaAlpha, Inc. (0001818383) (Issuer)

    2/25/26 7:45:15 PM ET
    $MAX
    Real Estate

    Director Nonko Eugene sold $251,031 worth of shares (25,097 units at $10.00), decreasing direct ownership by 1% to 946,543 units (SEC Form 4)

    4 - MediaAlpha, Inc. (0001818383) (Issuer)

    2/25/26 7:45:09 PM ET
    $MAX
    Real Estate

    Chief Legal Officer Mazzariello Gina sold $48,352 worth of shares (3,419 units at $14.14), decreasing direct ownership by 2% to 141,274 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    2/25/26 4:00:03 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 29, 2022 - FDA Approves New Treatment Option for Patients with ALS

    For Immediate Release: September 29, 2022 The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.  “This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure,” said Billy Dunn, M.D., director of the Off

    9/29/22 5:02:14 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 2, 2022 - FDA Roundup: September 2, 2022

    For Immediate Release: September 02, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:   On Thursday, the FDA published the FDA Voices: “Using A Whole-Of-Governments Approach to Combating Illicit Health Products,” by Cathy Hermsen, Assistant Commissioner for Criminal Investigations and Ritu Nalubola, Director of the FDA’s Europe Office. Crimi

    9/2/22 1:46:13 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Willdan Selected by Mt. SAC for $49 Million Distributed Energy and Resiliency Project

    Willdan Group, Inc. (NASDAQ:WLDN) announced today that it was selected by Mt. San Antonio College (Mt. SAC) in California to implement a $49 million energy services contract. The scope of work consists of the turnkey delivery of distributed energy resources (DERs) and infrastructure upgrades, including solar PV systems, a battery energy storage system, EV charging stations, and a comprehensive parking lot redesign. Construction is expected to be completed by the third quarter of 2027. Willdan is listed as a qualified energy service company in the state of California and holds a Master Services Agreement with the Foundation for California Community Colleges to implement DERs at California

    2/27/26 9:15:00 AM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    Domo Announces Timing of its Fourth Quarter and Full-Year Fiscal 2026 Earnings Conference Call

    Domo (NASDAQ:DOMO) today announced that results for its fourth quarter and full-year fiscal 2026 (ended January 31, 2026) will be released on Tuesday, March 10, 2026, after market close. The company will host a conference call at 3:00 p.m. (MT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live dial-in is available at (877) 484-6065 or (201) 689-8846. A live webcast of the event will also be available on the Domo Investor Relations website at www.domo.com/IR. A replay will be available at (877) 660-6853 or (201) 612-7415 with access ID# 13758775 following the completion of the conference call until 11:59 p.m. (ET) on April 10, 2026. About Domo Do

    2/27/26 9:00:00 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    reAlpha Tech Corp. Appoints Thomas Kutzman as Chief Financial Officer to Support Growth Strategy

    DUBLIN, Ohio, Feb. 27, 2026 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (NASDAQ:AIRE) (the "Company" or "reAlpha"), an AI-powered real estate technology company, today announced the appointment of Thomas Kutzman as Chief Financial Officer, effective February 25, 2026. Mr. Kutzman succeeds Piyush Phadke and will oversee the Company's financial operations, capital strategy, and key corporate functions such as human resources and legal, reporting directly to Chief Executive Officer Mike Logozzo. Kutzman brings more than 12 years of financial markets experience to the role. Prior to co-founding Prevu, he held investment and trading roles at SAC Capital, JPMorgan, Citi, and Jabre Capital Partners,

    2/27/26 8:30:00 AM ET
    $AIRE
    Real Estate
    Finance

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Financials

    Live finance-specific insights

    View All

    Domo Announces Timing of its Fourth Quarter and Full-Year Fiscal 2026 Earnings Conference Call

    Domo (NASDAQ:DOMO) today announced that results for its fourth quarter and full-year fiscal 2026 (ended January 31, 2026) will be released on Tuesday, March 10, 2026, after market close. The company will host a conference call at 3:00 p.m. (MT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live dial-in is available at (877) 484-6065 or (201) 689-8846. A live webcast of the event will also be available on the Domo Investor Relations website at www.domo.com/IR. A replay will be available at (877) 660-6853 or (201) 612-7415 with access ID# 13758775 following the completion of the conference call until 11:59 p.m. (ET) on April 10, 2026. About Domo Do

    2/27/26 9:00:00 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Delek US Holdings Reports Fourth Quarter 2025 Results

     Delek US reported fourth quarter net income of $78.3 million or $1.26 per share, adjusted net income of $143.0 million or $2.31 per share and adjusted EBITDA of $374.8 million Excluding the impacts of SREs, adjusted EPS was $0.44 per share and adjusted EBITDA was $225.5 million Further advanced key objectives of Enterprise Optimization Plan ("EOP") Increased the annual run-rate cash flow improvements to ~$200 million Recognized ~$50 million of improvements in 4Q'25 Announced restructuring of its Inventory Intermediation Agreement which will result in incremental free cash flow generation of at least $40 million Delek Logistics reported record financial performance and

    2/27/26 6:30:00 AM ET
    $DK
    $DKL
    Integrated oil Companies
    Energy
    Natural Gas Distribution

    Delek Logistics Reports Record Fourth Quarter 2025 Results

    Delek Logistics reported Net income of $47.3 million or $0.88 per unit Delivered record financial performance, Adjusted EBITDA of $142.3 million for the fourth quarter and $535.6 million for the year Progressed comprehensive acid gas injection (AGI) & sour gas treating solution at the Libby Gas Complex Initiated 2026 EBITDA Guidance of $520 - 560 million 2026 guidance reflects Increased economic separation from DK, as third-party EBITDA contribution to exceed 80% Continued our consistent distribution growth with our 52nd consecutive quarterly increase to $1.125/unit Delek Logistics Partners, LP (NYSE:DKL) ("Delek Logistics") today announced its financial results for the f

    2/27/26 6:30:00 AM ET
    $DKL
    Natural Gas Distribution
    Energy

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Critical Metals Corp.

    SC 13D/A - Critical Metals Corp. (0001951089) (Subject)

    12/13/24 4:10:59 PM ET
    $CRML
    Metal Mining
    Basic Materials

    $ADAP
    $AEVA
    $AIMD
    $AIRE
    Leadership Updates

    Live Leadership Updates

    View All

    reAlpha Tech Corp. Appoints Thomas Kutzman as Chief Financial Officer to Support Growth Strategy

    DUBLIN, Ohio, Feb. 27, 2026 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (NASDAQ:AIRE) (the "Company" or "reAlpha"), an AI-powered real estate technology company, today announced the appointment of Thomas Kutzman as Chief Financial Officer, effective February 25, 2026. Mr. Kutzman succeeds Piyush Phadke and will oversee the Company's financial operations, capital strategy, and key corporate functions such as human resources and legal, reporting directly to Chief Executive Officer Mike Logozzo. Kutzman brings more than 12 years of financial markets experience to the role. Prior to co-founding Prevu, he held investment and trading roles at SAC Capital, JPMorgan, Citi, and Jabre Capital Partners,

    2/27/26 8:30:00 AM ET
    $AIRE
    Real Estate
    Finance

    Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

    Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum

    2/24/26 8:00:00 AM ET
    $ESTA
    $GCO
    Industrial Specialties
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care